Stool for Fecal Calprotectin Test at Ayzal Lab

Stool for Fecal Calprotectin Test at Ayzal Lab

The Stool for Fecal Calprotectin test at Ayzal Lab in Lahore, Pakistan, is a highly specific, non-invasive laboratory investigation used to detect and monitor gastrointestinal inflammation. Calprotectin is a calcium- and zinc-binding protein found abundantly within the cytoplasm of neutrophils, which are a type of white blood cell. When inflammation occurs in the gastrointestinal tract, neutrophils migrate to the mucosal wall to combat the underlying trigger. During this active inflammatory response, these cells degranulate and release calprotectin directly into the intestinal lumen. Because this protein is remarkably stable and resistant to metabolic degradation within the stool for up to a week, measuring its concentration in a stool sample serves as an exceptionally reliable surrogate biomarker for localized intestinal inflammation.

This quantitative laboratory assay plays a pivotal clinical role in modern gastroenterology. Its primary diagnostic value lies in its high negative predictive value, which allows clinicians to confidently rule out active inflammatory bowel disease (IBD) in patients presenting with chronic abdominal symptoms. By utilizing advanced immunoassay technology, Ayzal Lab provides precise quantification of fecal calprotectin levels, helping healthcare providers differentiate between organic inflammatory conditions and functional gastrointestinal disorders, such as Irritable Bowel Syndrome (IBS). This differentiation is critical because, while the symptoms of IBS and IBD frequently overlap, their underlying pathophysiology, prognosis, and treatment pathways are vastly different. Utilizing this test helps patients avoid unnecessary, invasive endoscopic procedures like colonoscopies when inflammation is absent.

Clinical Importance and Diagnostic Value

The clinical utility of fecal calprotectin extends beyond initial diagnosis. For patients with established inflammatory bowel disease, including Crohn’s disease and Ulcerative Colitis, the test serves as an essential tool for disease monitoring. Regular assessment of calprotectin levels allows gastroenterologists to evaluate the patient’s response to therapeutic interventions, detect subclinical flare-ups before physical symptoms manifest, and confirm mucosal healing. By providing an objective, quantifiable measure of mucosal inflammation, the Stool for Fecal Calprotectin test at Ayzal Lab empowers medical specialists to make informed, timely decisions regarding medication adjustments, dietary modifications, and the necessity of follow-up diagnostic imaging or endoscopy.

Clinical Procedure: What to Expect

Patient Preparation

To ensure the utmost accuracy and clinical reliability of your Stool for Fecal Calprotectin test at Ayzal Lab, patients must adhere to specific preparation guidelines before sample collection:

• Medication Review: Inform your prescribing physician about all medications, supplements, and over-the-counter drugs you are currently taking.
• Avoid NSAIDs: Non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen, naproxen, and high-dose aspirin can cause mild, transient mucosal inflammation in the gut, leading to falsely elevated calprotectin levels. It is generally recommended to avoid these medications for at least 3 to 5 days prior to the test, under the guidance of your physician.
• Proton Pump Inhibitors (PPIs): Long-term use of PPIs (acid-reducing medications) may sometimes be associated with mild intestinal inflammation. Discuss with your doctor whether you need to temporarily pause these medications.
• No Laxatives: Do not use laxatives, mineral oil, or barium enemas immediately before collecting the stool sample, as these substances can dilute or contaminate the specimen.
• Active Infections: If you are experiencing an acute, self-limiting infectious diarrheal illness, consult your physician, as temporary infectious enteritis will naturally elevate calprotectin levels. The test is typically postponed until the infection resolves unless specifically ordered to assess acute colitis.

During the Procedure

The Stool for Fecal Calprotectin test is a completely non-invasive procedure requiring a self-collected stool specimen. Ayzal Lab provides a sterile, leak-proof specimen collection container with an integrated spoon or spatula attached to the cap. The sample collection process involves the following steps:

• Preparation: Wash your hands thoroughly with soap and water before starting the collection process.
• Avoid Contamination: Ensure the stool specimen does not come into contact with toilet water, urine, soap, or cleaning chemicals, as these will contaminate the sample and compromise the assay’s accuracy. You may use a clean, dry plastic collection unit or plastic wrap placed over the toilet bowl to catch the specimen.
• Sample Collection: Use the sterile spoon attached to the container cap to collect small portions of stool from different areas of the bowel movement, particularly focusing on any areas that appear unusual. Fill the container to the level indicated by the laboratory instructions (usually about one-third full or the size of a walnut for solid stool, or 5-10 mL for liquid stool).
• Securing the Container: Carefully close the container lid tightly to prevent leakage. Clean the outside of the container if necessary, and wash your hands thoroughly.
• Labeling and Transport: Ensure the container is clearly labeled with your full name, date of birth, and the exact date and time of collection. Deliver the sample to Ayzal Lab as soon as possible, ideally within 2 hours of collection. If a delay is unavoidable, store the sample in a refrigerator (do not freeze) according to the laboratory’s specific handling instructions.

When is a Stool for Fecal Calprotectin Test Performed?

Differentiating Between IBS and IBD

Physicians frequently request a fecal calprotectin test when a patient presents with chronic, non-specific gastrointestinal complaints such as abdominal pain, bloating, and altered bowel habits. Because Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD) share highly similar clinical presentations, this test serves as an essential triage tool. A normal calprotectin result strongly points toward a functional disorder like IBS, sparing the patient from invasive diagnostic procedures, whereas an elevated result indicates organic inflammation requiring further endoscopic evaluation.

Investigating Chronic Diarrhea

Chronic diarrhea lasting more than four weeks warrants a thorough diagnostic workup to identify the underlying cause. When infectious etiologies have been ruled out, a fecal calprotectin test is performed to determine if the diarrhea is driven by an active inflammatory process within the bowel mucosa. This helps clinical specialists narrow down the differential diagnosis to conditions such as microscopic colitis, Crohn’s disease, or malabsorptive disorders associated with mucosal inflammation.

Monitoring Inflammatory Bowel Disease (IBD) Activity

For patients already diagnosed with Crohn’s disease or Ulcerative Colitis, the fecal calprotectin test is performed at regular intervals to monitor disease activity. Because clinical symptoms do not always correlate perfectly with mucosal inflammation, serial calprotectin measurements provide an objective assessment of whether the disease is in deep remission or if subclinical inflammation is beginning to rise, allowing for proactive therapeutic adjustments.

Assessing Response to Therapeutic Interventions

Following the initiation of a new treatment regimen—such as biologics, immunomodulators, or specialized dietary therapies—physicians utilize the fecal calprotectin test to objectively evaluate treatment efficacy. A significant decline in calprotectin levels over weeks or months indicates a positive response to therapy and suggests that mucosal healing is occurring, which is the primary long-term goal of IBD management.

Evaluating Unexplained Weight Loss and Systemic Symptoms

When patients present with unexplained weight loss, persistent low-grade fever, or recurrent joint pain alongside mild gastrointestinal symptoms, systemic inflammatory diseases must be considered. A fecal calprotectin test is performed to investigate whether the gastrointestinal tract is the primary source of this systemic inflammatory response, helping direct the clinical team toward appropriate diagnostic pathways and specialist referrals.

What Does a Stool for Fecal Calprotectin Test Detect?

The quantitative measurement of fecal calprotectin can detect, monitor, or assist in the clinical evaluation of several gastrointestinal conditions and physiological states, including:

• Active mucosal inflammation within the large or small intestine
• Crohn’s disease activity and localization
• Ulcerative Colitis severity and extent of mucosal involvement
• Subclinical disease flare-ups in asymptomatic IBD patients
• Efficacy of anti-inflammatory, biologic, or immunosuppressive therapies
• Mucosal healing following successful medical intervention
• Infectious bacterial enteritis or colitis (e.g., Salmonella, Campylobacter, Clostridioides difficile)
• Parasitic infections causing significant intestinal mucosal damage
• Microscopic colitis (including collagenous and lymphocytic subtypes)
• Diverticulitis and localized peridiverticular inflammation
• Non-steroidal anti-inflammatory drug (NSAID)-induced enteropathy
• Gastrointestinal allergies, including eosinophilic gastroenteritis
• Presence of large colorectal polyps with associated surface inflammation
• Colorectal neoplasia or advanced adenomas with mucosal ulceration
• Active inflammation associated with Celiac disease (in some cases of severe mucosal damage)
• Radiation-induced proctitis or enteritis
• Ischemic colitis resulting from compromised blood flow to the bowel
• Juvenile polyps in pediatric patients presenting with rectal bleeding
• Intestinal graft-versus-host disease (GVHD) in post-transplant patients
• Food protein-induced enterocolitis syndrome (FPIES) in pediatric populations

Turnaround Time and Report Access at Ayzal Lab

At Ayzal Lab, we understand that receiving timely diagnostic results is crucial for patient peace of mind and prompt clinical decision-making. The Stool for Fecal Calprotectin test is processed using state-of-the-art immunoassay systems operated by highly trained laboratory technologists. The standard turnaround time for this specialized assay is typically within 24 to 48 hours from the time the specimen is received at our main laboratory facility. Once the analysis is completed and verified by our consultant pathologist, patients and their referring physicians are notified via SMS. Reports can be accessed securely online through the official Ayzal Lab patient portal, downloaded as a PDF, or collected in person from our diagnostic center.

Stool for Fecal Calprotectin Findings Overview

Structure / Parameter Evaluated	Normal Findings	Possible Abnormal Findings
Fecal Calprotectin Concentration	< 50 µg/g (Micrograms per gram of stool)	Elevated levels (> 50 µg/g to > 1000 µg/g) indicating active intestinal inflammation.
Neutrophilic Activity	Absent or minimal migration of neutrophils into the intestinal lumen.	Marked migration and degranulation of neutrophils due to mucosal injury or infection.
Intestinal Mucosal Integrity	Intact mucosal barrier with normal cellular junctions and no active ulceration.	Compromised mucosal barrier, epithelial erosion, or deep ulceration.
Therapeutic Response Indicator	Stable low levels indicating sustained clinical and mucosal remission.	Rising levels indicating therapeutic failure, non-adherence, or impending clinical relapse.
Diagnostic Differentiation	Strongly suggestive of functional bowel disorders (e.g., IBS) when symptoms are present.	Strongly suggestive of organic inflammatory pathology (e.g., IBD, colitis, or infection).
Pediatric Reference Range	Slightly higher baseline levels may be normal in infants under 1-5 years; interpreted contextually.	Significantly elevated levels indicating pediatric IBD, food protein allergies, or infections.
Specimen Quality & Stability	Homogeneous sample free from external contaminants, urine, or chemical diluents.	Diluted sample due to liquid stool, contamination, or improper storage leading to protein degradation.

Note: Diagnostic findings should always be interpreted by a qualified healthcare professional together with the patient’s symptoms, medical history, physical examination, laboratory investigations, previous imaging studies, and other relevant clinical information. Additional investigations or specialist consultation may be recommended depending on the findings.

Why Choose Ayzal Lab for Stool for Fecal Calprotectin?

• Experienced Healthcare Professionals: Our laboratory is staffed by highly qualified pathologists and technologists specializing in advanced clinical chemistry and immunology.
• Patient-Focused Care: We prioritize patient comfort, privacy, and convenience throughout the entire sample submission and reporting process.
• Quality Diagnostic Services: Ayzal Lab adheres to strict internal and external quality control protocols to ensure the highest accuracy of all test results.
• Professional Reporting: Our diagnostic reports are comprehensive, clear, and structured to provide maximum clinical utility for your treating physician.
• Modern Diagnostic Approach: We utilize advanced, validated immunoassay platforms to perform quantitative fecal calprotectin testing.
• Comfortable Environment: Our collection centers are designed to provide a clean, welcoming, and hygienic environment for all patients.
• Convenient Location: Located centrally in Lahore, Pakistan, our facilities are easily accessible for patients across the city.
• Commitment to Accurate Diagnosis: We are dedicated to delivering reliable, evidence-based diagnostic insights that form the foundation of effective medical treatment.